Dow Up2.00% Nasdaq Up1.66%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.47 Up 0.07(2.92%) Feb 12, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 12,996   5,184   2,178   8,250  
Cost of Revenue -   -   -   -  
Gross Profit 12,996   5,184   2,178   8,250  
Operating Expenses
Research Development15,501  15,059  15,702  14,613  
Selling General and Administrative4,276  4,099  4,717  16,005  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (6,781) (13,974) (18,241) (22,368)
Income from Continuing Operations
Total Other Income/Expenses Net109  62  48  96  
Earnings Before Interest And Taxes(6,672)(13,912)(18,193)(22,272)
Interest Expense -   -   -   -  
Income Before Tax(6,672)(13,912)(18,193)(22,272)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,672)(13,912)(18,193)(22,272)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,672) (13,912) (18,193) (22,272)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,672) (13,912) (18,193) (22,272)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.